In a major step forward toward advance cardiac care, Medanta-The Medicity, Noida, has successfully carried out its first three TAVI (Transcatheter Aortic Valve Implantation) procedures. This marks the ...
LONDON, England—If operators choose to continue a patient’s oral anticoagulation during TAVI, they are likely increasing bleeding without getting a benefit in the form of fewer thromboembolic events, ...
While it’s possible to protect the coronary ostia, sometimes with a stent and sometimes with leaflet modification, it might be in patients’ best interest if the heart team goes with surgical aortic ...
May 23, 2011 (Paris, France) — If a patient being considered for transcatheter aortic-valve implantation (TAVI) is found to have coronary disease, should that be treated as well? That's a question ...
CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed. In a ...
Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...
LONDON -- It was best that people interrupt their oral anticoagulation (OAC) therapy around the time they get transcatheter aortic valve replacement (TAVR, also TAVI), the POPular PAUSE TAVI trial ...
NICE, France--(BUSINESS WIRE)--Caranx Medical (“Caranx”), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve ...
In that high-risk group, in-hospital mortality was "just as good, if not better" with TAVI as with conventional aortic-valve surgery, said Dr Christian W Hamm (Kerckhoff Heart and Thorax Centre, Bad ...
Caranx Medical Announces First Clinical Use of the TAVIPILOT Soft, Cleared by FDA for Commercial in July: the World First AI Software for Real-Time Intra-Operative Guidance of Transcatheter Heart ...
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were ...
NICE, France--(BUSINESS WIRE)--Caranx Medical (‘Caranx’), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results